Smoking Cessation Using Motivational Therapy and Varenicline

Completed · Not applicable

Conditions studied: Smoking, HIV Infections

In brief

People that are infected with HIV appear to be especially susceptible to the adverse effects of cigarette smoking. The purpose of this study is to determine if quitting smoking by using a specialized smoking cessation treatment can prevent one from developing accelerated lung damage, particularly emphysema.

Key facts

Study ID

NCT00701896

Run by

Philip Diaz

People needed

294

Starts

2008-10-03

Expected to finish

2013-06-20

Last updated by the study team

2021-01-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age and older;
• diagnosis of HIV;
• self-reported smoking on a daily basis;
• provide informed written consent

You may not qualify if…

• persons with active psychosis or impaired mental status as judged by the clinic staff and confirmed with a Mini-Mental Status Exam)
• unable to understand spoken English
• age less than 18 years.
• pregnant women

Where it is running

• The Ohio State University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.